$0.47 EPS Expected for Merit Medical Systems, Inc. (NASDAQ:MMSI) This Quarter

Analysts predict that Merit Medical Systems, Inc. (NASDAQ:MMSIGet Rating) will report earnings of $0.47 per share for the current quarter, Zacks Investment Research reports. Four analysts have made estimates for Merit Medical Systems’ earnings. The highest EPS estimate is $0.48 and the lowest is $0.45. Merit Medical Systems reported earnings per share of $0.52 in the same quarter last year, which would suggest a negative year-over-year growth rate of 9.6%. The company is expected to issue its next earnings report on Monday, January 1st.

On average, analysts expect that Merit Medical Systems will report full-year earnings of $2.49 per share for the current financial year, with EPS estimates ranging from $2.44 to $2.55. For the next financial year, analysts anticipate that the firm will report earnings of $2.78 per share, with EPS estimates ranging from $2.70 to $2.85. Zacks’ EPS averages are a mean average based on a survey of sell-side analysts that follow Merit Medical Systems.

Merit Medical Systems (NASDAQ:MMSIGet Rating) last released its quarterly earnings data on Thursday, February 24th. The medical instruments supplier reported $0.71 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.50 by $0.21. Merit Medical Systems had a return on equity of 13.54% and a net margin of 4.51%. The business had revenue of $278.50 million for the quarter, compared to analysts’ expectations of $270.96 million. During the same quarter in the previous year, the business posted $0.54 EPS. Merit Medical Systems’s revenue for the quarter was up 7.9% on a year-over-year basis.

MMSI has been the subject of several research analyst reports. StockNews.com lowered Merit Medical Systems from a “strong-buy” rating to a “buy” rating in a research report on Tuesday, April 5th. Piper Sandler decreased their price objective on Merit Medical Systems from $79.00 to $75.00 in a research report on Friday, February 25th. TheStreet upgraded Merit Medical Systems from a “c” rating to a “b-” rating in a research report on Friday, February 25th. Needham & Company LLC reduced their price target on Merit Medical Systems from $83.00 to $73.00 and set a “buy” rating for the company in a research report on Friday, February 25th. Finally, Raymond James reduced their price target on Merit Medical Systems from $73.00 to $72.00 and set an “outperform” rating for the company in a research report on Friday, February 25th. One investment analyst has rated the stock with a hold rating and five have assigned a buy rating to the company. Based on data from MarketBeat, the stock presently has an average rating of “Buy” and an average price target of $75.20.

Large investors have recently added to or reduced their stakes in the business. BNP Paribas Arbitrage SA boosted its position in Merit Medical Systems by 181.8% during the 3rd quarter. BNP Paribas Arbitrage SA now owns 49,055 shares of the medical instruments supplier’s stock worth $3,522,000 after acquiring an additional 31,650 shares during the last quarter. Emerald Mutual Fund Advisers Trust raised its stake in shares of Merit Medical Systems by 22.5% during the 3rd quarter. Emerald Mutual Fund Advisers Trust now owns 472,218 shares of the medical instruments supplier’s stock worth $33,905,000 after purchasing an additional 86,729 shares in the last quarter. FDx Advisors Inc. raised its stake in shares of Merit Medical Systems by 15.2% during the 4th quarter. FDx Advisors Inc. now owns 7,919 shares of the medical instruments supplier’s stock worth $493,000 after purchasing an additional 1,043 shares in the last quarter. Bank of New York Mellon Corp raised its stake in shares of Merit Medical Systems by 8.8% during the 3rd quarter. Bank of New York Mellon Corp now owns 587,833 shares of the medical instruments supplier’s stock worth $42,206,000 after purchasing an additional 47,320 shares in the last quarter. Finally, Strs Ohio raised its stake in shares of Merit Medical Systems by 7.1% during the 4th quarter. Strs Ohio now owns 22,700 shares of the medical instruments supplier’s stock worth $1,414,000 after purchasing an additional 1,500 shares in the last quarter. 95.93% of the stock is owned by hedge funds and other institutional investors.

Shares of MMSI traded down $0.60 on Wednesday, hitting $67.41. The company’s stock had a trading volume of 8,414 shares, compared to its average volume of 350,413. The company has a quick ratio of 1.10, a current ratio of 2.04 and a debt-to-equity ratio of 0.23. The firm’s fifty day moving average price is $61.89 and its 200-day moving average price is $63.99. Merit Medical Systems has a fifty-two week low of $51.66 and a fifty-two week high of $73.85. The firm has a market capitalization of $3.81 billion, a price-to-earnings ratio of 79.60, a P/E/G ratio of 2.60 and a beta of 1.03.

About Merit Medical Systems (Get Rating)

Merit Medical Systems, Inc designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures, primarily in cardiology, radiology, oncology, critical care, and endoscopy. The company operates in two segments, Cardiovascular and Endoscopy.

Featured Articles

Get a free copy of the Zacks research report on Merit Medical Systems (MMSI)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Merit Medical Systems (NASDAQ:MMSI)

Receive News & Ratings for Merit Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merit Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.